Dr. Bivin Wilson – Consultant Interventional Cardiologist




8 AM to 4 Pm
  • MD -  Goa University,  12\2011
  • DNB Cardiology - National Board of Examinations, 2011
  • Indian Medical Association
  • Cardiological Society of India
  • Indian College of Cardiology
  • Member of Formulary Committee, GKNM Hospital
  • Since 2015 Editorial Board Member – Journal of experimental  cardiology and research: Jacobs Publishers
  • 19/07/14 - Performance Excellence Award  by G.K.N.M. Hospital, Coimbatore
  • International Case presentation: Presented 2 interesting cases of CTO in CTO Live course conducted by NHCS October 2013 Singapore and was selected for second best case award.
  • 08/07/18  Distinguished Service to Community Award by IMA Coimbatore and IACC Tamilnadu.
  • “Primary congenital anomalies of the coronary arteries and relation to atherosclerosis - an angiographic study in south Indian population” , Indian Heart Journal 2013 December Supplement 1 volume 65
  • “An interesting case of straight back syndrome and review of the literature” Asian Cardiovasc Thorac Ann 2014 Jun 6
  • “Left ventricular pseudoaneurysm following balloon mitral valvuloplasty”, Cardiovasc.Thorac Ann. 2014 Mar. 17
  • Multivessel coronary artery Myocardial bridging in unusual locations,  Cardiovasc Thorac Ann. 2014 Apr 9. PMID: 24719159
  • A rare image of myocardial bridging in right coronary artery territory Asian Cardiovasc Thorac Ann. 2014 Feb 11. PMID: 24585296
  • Rare presentation of Takotsubo cardiomyopathy following total thyroidectomy for carcinoma thyroid , International journal of contemporary Medicine.
  • “An Unusual cause of cardiac failure in adults”, International journal of contemporary Medicine.
  • “A rare case of pregnancy associated cardiomyopathy in antiphospholipid antibody syndrome complicated by severe pre eclampsia” and got accepted for publication in International journal of contemporary surgery.
  • Submitted an interesting case of Stavudine induced Metabolic Acidosis in the journal “THE INDIAN PRACTITIONER” in October 2006 edition.
  • Text Book Chapters :    Co authored a chapter in the book CSI- Cardiology Update 2013:Tricks and techniques in transradial percutaneous coronary interventions, Ed,K.Venugopal K, Cardiology Society of India, 2013: 187-192.
MULTICENTER CLINICAL TRIALS Co-Investigator in the following ongoing Clinical Trials at G.Kuppuswamy Naidu Memorial Hospital, Coimbatore : Phase III trials :
  • Evaluation of the safety and efficacy of APIXIBAN in Acute Coronary Syndrome a double blinded, placebo controllled, event driven, multi-centric study.
  • CANTOS study - A randomized, double-blind, placebo-controlled, event-driven trial of quarterly subcutaneous canakinumab in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with elevated hsCRP.
  • REDUCE-IT (Reduction of Cardiovascular Events with EPA-Intervention Trial) : A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardiovascular Disease .
  • TDE PH-310 : A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-controlled, Event Driven Study to Compare the Time to First Clinical Worsening in Subjects with Pulmonary Arterial Hypertension receiving UT-15C in Combination with a PDE5-I or ERA Compared with a PDE5-I or ERA Alone.
  • TDE PH-311 : An open-Label Extension study of UT 15C in subjects with Pulmonary Arterial Hypertension.  A Long-Term Follow up to protocol TDE-PH-310.
Investigator Initiated trial :
  • The Strategy of Routine Emergent Thrombosuction followed by Interval Angioplasty in Acute Myocardial Infarction – STRENGTH STUDY (Single centre)
Post Marketing Trials :
  • TUXEDO-India: A Prospective, Single Blind, Multi-centre, Randomized Trial to Compare the TAXUS ElementTM Coronary Stent System against the XIENCE Prime Coronary Stent System in the treatment of Diabetic Patients PopulatiOn in India.
  • A Prospective, Multi Centre Registry to assess Everolimus – Eluting Coronary Stent System (Promus Element) for Coronary revascularization in an Indian population of unrestricted patients.